REGULATORY RELIANCE PROGRAMS YOUR GLOBAL MEDICAL DEVICE APPROVALS

In today’s globalized medical device market, manufacturers face the challenge of navigating multiple regulatory systems across various jurisdictions. The process of obtaining medical device approvals can be time-consuming, expensive, and resource-intensive, especially when similar evaluations are conducted in multiple regions. But what if there was a way to streamline this process and reduce duplication? Enter Regulatory Reliance Programs, a concept gaining momentum in the medical device industry. One of the most recognized examples is the Medical Device Single Audit Program (MDSAP) Audit, which allows a single MDSAP audit to satisfy quality management system requirements for multiple participating regulatory authorities. These programs enable regulators to leverage the work of trusted bodies, significantly reducing the time and resources spent on approvals. As a result, manufacturers can accelerate medical device market access while maintaining compliance across different jurisdictions.

WHAT IS REGULATORY RELIANCE?

Regulatory reliance occurs when a regulatory authority in one region accepts the regulatory decisions or assessments made by another trusted authority. This approach helps eliminate unnecessary duplicate evaluations, reducing costs and improving efficiency. For manufacturers seeking faster medical device approvals, regulatory reliance can significantly simplify the pathway to global expansion. A well-known example supporting this model is the Medical Device Single Audit Program (MDSAP), where a single MDSAP audit can satisfy quality management system requirements for multiple participating regulators. Instead of undergoing separate inspections in different countries, manufacturers can leverage one consolidated audit, supporting smoother medical device market access across multiple jurisdictions. In simpler terms, rather than repeating the same approval process in every region, participating regulatory authorities rely on evaluations, inspections, or approval decisions already performed by a trusted regulator. This collaborative approach accelerates medical device approvals while maintaining high standards of safety and compliance.

Section	Key Update/Consideration
Introduction	Regulatory reliance is promoted to streamline medical device approval, improving access to safe and effective devices. The playbook offers strategies for implementing reliance programs.
Scope	Reliance can be applied across the product lifecycle and used in public health emergencies (e.g., pandemics). Legal frameworks and varying reliance mechanisms should be considered.
Definitions	Key terms like “Reliance,” “Work-Sharing,” and “Recognition” are defined, emphasizing the interconnectedness of regulatory reliance, convergence, and harmonization.
Types of Regulatory Reliance	Highlights various types, including Work-Sharing (e.g., MDSAP), Abridged Regulatory Pathways (e.g., ANVISA), and Recognition (e.g., TGA and MHRA mutual recognition).
Considerations Prior to Developing a Program	Regulatory authorities (RAs) need to assess legal frameworks, resources, and the compatibility of their needs with potential reference regulatory authorities (RAs).
Steps to Develop a Reliance Program	Focuses on establishing scope, defining activities, selecting reference RAs, and creating agreements for information sharing and work-sharing.
Stakeholder Engagement	Engaging internal and external stakeholders (e.g., manufacturers, patients) is critical for the success of reliance programs. Training, feedback, and transparency are essential.
Legal Framework	Identifying how reliance can be integrated into existing laws and regulations, with phased approaches based on the legal constraints of each jurisdiction.
Management System for Reliance Programs	Establishing systems to monitor processes, measure performance, collect feedback, and allow for continuous improvement.
Evaluation Questions for Reference RAs	The annex provides a list of questions to evaluate the suitability of potential reference regulatory authorities, including classifications, post-market surveillance, and QMS.

Source : Playbook for Medical Device Regulatory Reliance Programs

WHY SHOULD MANUFACTURERS CARE?

For manufacturers, regulatory reliance programs can offer several significant advantages:

Faster Market Access: If your device is already approved in one trusted market (like the US or the EU), regulatory authorities in other regions that participate in reliance programs may expedite approval based on the existing evaluations.
Cost Savings: By leveraging decisions made by trusted authorities, manufacturers can reduce the need to submit the same information multiple times, thus lowering costs related to regulatory processes.
Streamlined Compliance: Regulatory reliance allows manufacturers to avoid unnecessary documentation and redundant reviews, making it easier to navigate the global regulatory landscape.
Efficiency for Small and Medium Enterprises: For smaller manufacturers, regulatory reliance programs can be a game-changer by minimizing the regulatory burden, allowing them to focus more on innovation and market expansion.

KEY TYPES OF REGULATORY RELIANCE PROGRAMS

There are several types of regulatory reliance that authorities can adopt, depending on the needs and goals of the jurisdiction. Let’s break down the main types:

Work-Sharing: This is a collaborative approach where multiple regulatory authorities share tasks such as joint inspections or application reviews. One notable example is the Medical Device Single Audit Program (MDSAP) Audit, which allows a single audit to satisfy multiple regulatory requirements.
Regulatory Pathway: In this scenario, a regulatory authority simplifies its evaluation by accepting the assessments or approvals from a trusted reference authority. This is ideal for devices already approved in another jurisdiction with similar regulatory requirements.
Recognition: This type of reliance involves directly accepting the decision of another authority, with minimal or no additional review. For instance, the Therapeutic Goods Administration (TGA) in Australia recognizes decisions made by certain reference authorities, enabling faster approvals for devices previously approved in other countries.

HOW MANUFACTURERS CAN BENEFIT

For medical device manufacturers, these reliance programs are incredibly beneficial. Here’s how they can be leveraged for competitive advantage:

Global Market Reach: Regulatory reliance helps manufacturers quickly expand into new markets with minimal additional regulatory hurdles. Once approved in one jurisdiction, manufacturers can fast-track their devices in others with similar regulatory systems.
Reduced Regulatory Burden: Instead of repeating the same evaluations in every jurisdiction, reliance programs enable manufacturers to provide documentation or approvals from trusted authorities, streamlining the process.
Faster Time to Market: With shorter approval timelines, manufacturers can get their products into the hands of patients and healthcare providers faster, which is especially crucial in emergency situations, like public health crises.

STEPS TO IMPLEMENT A REGULATORY RELIANCE PROGRAMS

If you’re a regulatory authority looking to set up or improve a regulatory reliance program, there are a few key steps to consider:

Understand Your Legal Framework: Before implementing a reliance program, it’s crucial to assess your jurisdiction’s legal framework to determine whether changes are necessary to accommodate reliance practices.
Identify Reference Regulatory Authorities: You’ll need to identify trusted regulatory bodies whose decisions you can rely on. This involves researching their regulatory processes and determining how their assessments align with your own requirements.
Define the Scope of Reliance: Not all regulatory activities need to be part of a reliance program. Decide which aspects, such as pre-market evaluations or post-market surveillance, will benefit from reliance.
Engage Stakeholders: A reliance program impacts multiple stakeholders, including medical device manufacturers, healthcare providers, and regulatory bodies. Early and continuous engagement is essential for smooth program implementation.
Implement Information-Sharing Agreements: For most reliance programs, particularly those involving work-sharing or recognition, information-sharing agreements are crucial. These agreements ensure that the necessary data is accessible to make informed decisions.

CHALLENGES AND CONSIDERATIONS

While regulatory reliance programs offer clear benefits, there are a few challenges to keep in mind:

Differences in Regulatory Frameworks: Not all regulatory authorities follow the same rules or have identical processes. Regulatory bodies need to carefully assess the compatibility of their frameworks before entering into reliance agreements.
Legal and Privacy Concerns: Some jurisdictions may have strict laws regarding data sharing or the acceptance of external regulatory decisions. These legal complexities must be navigated carefully to avoid issues later on.
Stakeholder Concerns: Manufacturers and other stakeholders may have concerns about how reliance programs will impact their ability to access markets or the level of scrutiny their products will face. Clear communication and transparency can help alleviate these concerns.

THE FUTURE OF REGULATORY RELIANCE PROGRAMS IN MEDICAL DEVICES

As the global medical device industry continues to grow, the adoption of regulatory reliance programs is expected to increase. These programs offer a way to reduce duplication, optimize resources, and improve efficiency across borders. For manufacturers, this means quicker access to new markets, reduced regulatory costs, and fewer delays. By understanding how reliance works and preparing for its implementation, medical device manufacturers can position themselves to take advantage of these global regulatory shifts. Embracing reliance is not just about meeting the requirements of today, it’s about preparing for the demands of tomorrow’s rapidly evolving medical device landscape.

HOW MORULAA CAN HELP

At Morulaa, we simplify the process of obtaining global medical device approvals through regulatory reliance programs. We assist manufacturers in capitalizing trusted authorities like the FDA and CE to expedite market access across multiple regions. By utilizing programs like the Medical Device Single Audit Program (MDSAP), we help you streamline compliance and reduce excessive evaluations. Our expertise ensures your device meets the requirements of various authorities, making your market expansion smoother and more efficient. We also provide ongoing support to ensure continued compliance, helping you navigate the complexities of global regulations and succeed in new markets.